Early Signs of Juvenile Rheumatoid Arthritis
Links shared publicly online about this topic
Juvenile Rheumatoid Arthritis
kidshealth.org — “The most prevalent form of juvenile arthritis, juvenile rheumatoid arthritis, affects some 50,000 kids in the United States. Learn more.” View full resource at kidshealth.org
Most Recently Shared on June 30, 2009 at 5:21 pm By:
Juvenile Rheumatoid Arthritis: http://ow.ly/g9EY
Rheumatology Article | Arthritis, Juvenile Rheumatoid
mdlinx.com — “Aggressive combination drug therapy in very early polyarticular juvenile idiopathic arthritis (ACUTE-JIA): A multicentre randomised open-label clinical trial” View full resource at mdlinx.com
Most Recently Shared on June 13, 2011 at 8:04 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Aggressive combination drug therapy in very early polyarticular juvenile idiopathic arthritis (ACU... http://bit.ly/itMybT #Rheumatology
Rheumatology Article | Juvenile idiopathic arthritis
mdlinx.com — “Synovial membrane immunohistology in early untreated juvenile idiopathic arthritis: differences between clinical subgroups” View full resource at mdlinx.com
Most Recently Shared on June 22, 2011 at 9:34 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Synovial membrane immunohistology in early untreated juvenile idiopathic arthritis: differences be... http://bit.ly/lGbipy #Rheumatology
ACTEMRA reduces signs, symptoms in patients with rheumatoid arthritis
twurl.nl — “Genentech, Inc., a member of the Roche Group today announced updated data from a Phase III study (ROSE) that showed rheumatoid arthritis (RA) patients receiving ACTEMRA (tocilizumab) experienced a rapid, measured response as early as one week after beginning ACTEMRA, and improvement in disease activity within four weeks.” View full resource at twurl.nl
Most Recently Shared on November 8, 2010 at 11:36 am By:
Stroke News: ACTEMRA reduces signs, symptoms in patients with rheumatoid arthritis: Genentech, Inc., a member ... http://twurl.nl/6p6ovr
ACTEMRA reduces signs, symptoms in patients with rheumatoid arthritis
news-medical.net — “Genentech, Inc., a member of the Roche Group today announced updated data from a Phase III study (ROSE) that showed rheumatoid arthritis (RA) patients receiving ACTEMRA (tocilizumab) experienced a rapid, measured response as early as one week after beginning ACTEMRA, and improvement in disease activity within four weeks.” View full resource at news-medical.net
Most Recently Shared on November 8, 2010 at 12:41 pm By:
ACTEMRA reduces signs, symptoms in patients with rheumatoid arthritis: Genentech, Inc., a member of the Roche Gr... http://bit.ly/dbhtqB
ACTEMRA reduces signs, symptoms in patients with rheumatoid arthritis
news-medical.net — “Genentech, Inc., a member of the Roche Group today announced updated data from a Phase III study (ROSE) that showed rheumatoid arthritis (RA) patients receiving ACTEMRA (tocilizumab) experienced a rapid, measured response as early as one week after beginning ACTEMRA, and improvement in disease activity within four weeks.” View full resource at news-medical.net
Most Recently Shared on November 8, 2010 at 7:28 am By:
ACTEMRA reduces signs, symptoms in patients with rheumatoid arthritis: Genentech, Inc., a member of the Roche Gr... http://bit.ly/a270wI
Failure to act on early signs of rheumatoid arthritis could prove fatal | Science | The Guardian
guardian.co.uk — “Specialist says rheumatoid arthritis can be halted or even reversed if treated early, but symptoms are often ignored” View full resource at guardian.co.uk
Most Recently Shared on September 15, 2010 at 5:54 pm By:
Guardian Science Science Enthusiast
Failure to act on early signs of rheumatoid arthritis could prove fatal http://bit.ly/cKuP5X
Rheumatology Article | Osteoprotegerin Arthritis Arthritis, Juvenile Rheumatoid
mdlinx.com — “Serum levels of osteoprotegerin and receptor activator of nuclear factor -kappaB ligand in children with early juvenile idiopathic arthritis: A 2-year prospective controlled study” View full resource at mdlinx.com
Most Recently Shared on December 9, 2010 at 8:37 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Serum levels of osteoprotegerin and receptor activator of nuclear factor -kappaB ligand in childre... http://bit.ly/hGKuav #Rheumatology
What are the symptoms and signs of rheumatoid arthritis? | BJC Connected Care
bjchealth.com.au — “Rheumatoid arthritis commonly affects the small joints of the hands and feet in a symmetrical pattern; however, the large joints such as elbows, shoulders,” View full resource at bjchealth.com.au
Most Recently Shared on August 24, 2011 at 6:20 pm By:
Rheumatology Medical News about Arthritis, Juvenile Rheumatoid
mdlinx.com — “Early identification of juvenile idiopathic arthritis” View full resource at mdlinx.com
Most Recently Shared on February 9, 2010 at 3:05 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Rheum: Early identification of juvenile idiopathic arthritis: The Journal of Musculoskeletal Medicine http://bit.ly/b1XFU5
Early diagnosis of Rheumatoid Arthritis - StreamingWell.com
streamingwell.com — “Getting a referral to a Rheumatologist is critically important at the first symptoms or signs of Rheumatoid Arthritis. In this film, a Rheumatology expert and a person with RA explore how a rapid referral can prevent irreversible joint damage.” View full resource at streamingwell.com
Most Recently Shared on May 31, 2011 at 12:28 pm By:
RT @FrancisNamouk: Just launched our new @StreamingWell video rating (beta) tool! http://j.mp/mt7o1G Thoughts? #hcsmeu #hcsmuk
Early treatment key to extending life - The Irish Times - Thu, Sep 16, 2010
irishtimes.com — “RHEUMATOID ARTHRITIS:THOSE SHOWING signs of rheumatoid arthritis should seek treatment immediately and not delay. Modern drugs can halt the disease, but early treatment can prolong life, according to a consultant dealing with the disease.” View full resource at irishtimes.com
Most Recently Shared on September 16, 2010 at 1:32 am By:
Early treatment key to extending life: RHEUMATOID ARTHRITIS:THOSE SHOWING signs of rheumatoid arthritis should see... http://bit.ly/bOJ6qK
Arthritis Forum - Topix
topix.com — “Forums and message boards for Arthritis.” View full resource at topix.com
Most Recently Shared on June 3, 2011 at 5:47 pm By:
Morgan Kalman Clinic in Wilmington, DE.
Sports Medicine Fellowship Thomas Jefferson University Hospital.
Certificate in Physical Therapy Columbia University in NYC
B.A. Gettysburg College (PA)
Certified in Age Management Medicine by Cenegenics Education and Research Foundation
Dr.
Kalman’s area of expertise involves, but is not limited to,
Arthroscopic surgery of the hip, knee, shoulder and elbow.
He is trained in ultrasound guided injections and PRP (platelet rich plasma) to help recovery from injury.
He
has lectured nationally and is published in peer reviewed journals.
He is an Associate Master Instructor for arthroscopic surgery of
the hip, knee and shoulder at the Orthopaedic Learning Center in
Rosemont, Illinois for the Arthrosopy Association of North America.
Sports Medicine consultant for the University of Delaware and local high schools.
Co-Founder of Fieldhouse Wellness in Malvern, PA, a multi-disciplinary approach patient well being.
" /> Dr Vic Kalman Orthopedic Surgeon, Physician, Doctor, Active Health Library, Surgeon, and Sports Medicine Doctor
Fibromyalgia still somewhat mysterious - Topix: Questions surround fibromyalgia, which produces chronic pain and... http://bit.ly/int1Nw
Early Communication About an Ongoing Safety Review of Tumor Necrosis Factor (TNF) Blockers (marketed as Remicade, Enbrel, Humira, and Cimzia)
fda.gov — “Early Communication About an Ongoing Safety Review of Tumor Necrosis Factor (TNF) Blockers (marketed as Remicade, Enbrel, Humira, and Cimzia)” View full resource at fda.gov
Most Recently Shared on August 5, 2009 at 4:45 pm By:
FDA warns of possible connection between drugs for inflammatory disorders and cancer in kids: http://bit.ly/BvQDV
Study: Actemra better than placebo in late-stage trial - Related Stories - AAP SmartBrief
smartbrief.com — “More patients who took Roche Holding's Actemra had reduced signs and symptoms of systemic onset juvenile idiopathic arthritis than those given placebo after 12 weeks of treatment in a Phase III trial. The finding adds to evidence of Actemra's efficacy for arthritis, including another late-stage stud” View full resource at smartbrief.com
Most Recently Shared on November 20, 2009 at 11:14 pm By:
Clara Song Pediatrician, Physician, and Doctor
Study: Actemra better than placebo in late-stage trial http://sbne.ws/r/3jBZ
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
KidsHealth
KidsHealth is the most-trusted website for health and development information written for parents, kids and teens.
-
Sandeep Pulim MD
Over 2K medical journal articles & health news summarized and delivered FREE to 35 specialties daily. Oncology, Rheumatology, Cardiology, Neurology, Psychiatry
-
Sandeep Pulim MD
Over 2K medical journal articles & health news summarized and delivered FREE to 35 specialties daily. Oncology, Rheumatology, Cardiology, Neurology, Psychiatry
Advertisement
